CRYOPRESERVATION EQUIPMENT MARKET ANALYSIS

Cryopreservation Equipment Market, by Equipment (Freezers (Cryopreservation Freezers, Drystore Freezers), Incubators, Sample Preparation System, and Accessories), by Cryogen (Liquid Nitrogen, Oxygen, Argon, and Liquid helium), by Application (Cord Blood Stem Cells, Sperms, Semen & Testicular Tissues, Embryos & Oocytes, Other Application), by End User (Stem Cells Banks, Biotechnology and Pharmaceutical organizations, Contract Research Organizations, Stem Cell Research Laboratories, and Research and Academic Institutes), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Jul 2022
Code : CMI1356
Pages :180
Formats :
Excel and PDF
Industry : Medical Devices

Market News

Global Cryopreservation Equipment Market: Key Developments

In April 6 2022, TC Biopharm Plc., a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and viral indications, had successfully registered the UK trademark "CryoTC", for the Company's proprietary process for freezing and thawing of its lead oncology product, OmnImmune. CryoTR is TC BioPharm's unique process of cryopreservation, which is performed in a controlled rate freezer using an optimized protocol. OmnImmune is an allogeneic unmodified cell therapy consisting of activated and expanded gamma delta T cells.